Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) was the target of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 185,000 shares, a decrease of 27.5% from the October 31st total of 255,300 shares. Approximately 3.0% of the company’s stock are sold short. Based on an average daily trading volume, of 88,900 shares, the days-to-cover ratio is currently 2.1 days.
Insider Buying and Selling at Bullfrog AI
In other news, CEO Vininder Singh sold 14,405 shares of the firm’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $2.65, for a total value of $38,173.25. Following the completion of the sale, the chief executive officer now owns 2,478,041 shares of the company’s stock, valued at $6,566,808.65. This trade represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Over the last ninety days, insiders sold 31,603 shares of company stock valued at $82,989. 33.90% of the stock is currently owned by insiders.
Institutional Trading of Bullfrog AI
An institutional investor recently bought a new position in Bullfrog AI stock. Renaissance Technologies LLC bought a new position in Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,800 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned about 0.25% of Bullfrog AI as of its most recent SEC filing. Institutional investors own 0.96% of the company’s stock.
Bullfrog AI Stock Performance
Bullfrog AI Company Profile
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Read More
- Five stocks we like better than Bullfrog AI
- How to Calculate Stock Profit
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 11/25 – 11/29
- ESG Stocks, What Investors Should Know
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.